IMPACT Medicom

By IMPACT Medicom

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.

Image by IMPACT Medicom

Category: Science

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 0
Reviews: 0
Episodes: 57

Description

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com. 


Episode Date
Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion
Aug 19, 2026
Introduction to the Canadian Hematology Consensus Group (CHCG)
May 29, 2026
Double-Exposed CLL/SLL: A Canadian Perspective
Dec 02, 2025
Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy
Nov 10, 2025
Highlights from EHA/ICML 2025: International Perspective on CLL
Jun 26, 2025
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH
Mar 27, 2025
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL
Mar 26, 2025
ASH 2024: Updates on CLL
Dec 29, 2024
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
Sep 04, 2024
Highlights from EHA 2024 - Updates on the Treatment of CLL
Jul 02, 2024
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
Jun 21, 2024
Cutting Edge Advances in the Treatment of Lung Cancer
Apr 19, 2024
Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers
Apr 18, 2024
Immunotherapy for Kidney Transplant Patients with Skin Cancer
Mar 25, 2024
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
Mar 25, 2024
LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM
Dec 18, 2023
Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL
Dec 07, 2023
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC
Oct 26, 2023
First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion
Sep 18, 2023
First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion
Sep 18, 2023
First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment
Sep 18, 2023
First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs
Sep 18, 2023
Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing
Jun 19, 2023
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyperglycemia
Jun 05, 2023
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Introduction to EV
Apr 28, 2023
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Skin Reactions
Apr 28, 2023
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Peripheral Neuropathy
Apr 27, 2023
Live from CCOLD - Treatment of CLL
Apr 03, 2023
Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL
Mar 23, 2023
Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer
Mar 13, 2023
Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL
Dec 19, 2022
ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL
Dec 13, 2022
Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer
Sep 16, 2022
Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301
Jun 16, 2022
Immunotherapy for Cervical Cancer
May 24, 2022
Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist
May 19, 2022
Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer
May 02, 2022
Immunotherapy in HNSCC Series: Ep 2 - Perspectives from Surgical Oncology
Apr 25, 2022
Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing
Apr 04, 2022
Triple Negative Breast Cancer: Immunotherapies and Biomarkers
Mar 21, 2022
Precision Medicine in Oncology: Ep.10. Biomarkers in Gastrointestinal Malignancies
Feb 07, 2022
Precision Medicine in Oncology: Ep.9 DEBATE - Is PARP inhibitor maintenance therapy in first-line BRCA mutated ovarian cancer a curative-intent strategy?
Jan 07, 2022
Precision Medicine in Oncology: Ep.8. Importance of BRCA testing for Advanced Epithelial Ovarian Cancer
Dec 07, 2021
Precision Medicine in Oncology Podcast Series: Ep7. Importance of Genetic Testing in Patients with Prostate Cancer
Nov 29, 2021
Precision Medicine in Oncology: Ep.6 Biomarker testing in metastatic colorectal cancer – mismatch repair and beyond
Nov 26, 2021
Zanubrutinib for the Treatment of Waldenstrom's Macroglobulinemia
Oct 22, 2021
Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer
Sep 27, 2021
Lung Cancer Screening: Ontario
Sep 02, 2021
Lung Cancer Screening: Western Canada
Sep 02, 2021
Dépistage du Cancer Du Poumon: Québec
Sep 02, 2021
Lung Cancer Screening: National
Sep 01, 2021
Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec
Jul 13, 2021
Treatment of Relapsed/Refractory Hodgkin's Lymphoma
Jul 09, 2021
Chronic Lymphocytic Leukemia (CLL): How do we Manage Patients During COVID-19?
Oct 28, 2020
Virtual Patient Management during COVID-19: How can we best Manage Patients with Inflammatory Arthritis?
Oct 23, 2020
The Opioid Epidemic in Canada: What Can We Do?
Oct 22, 2020
COVID-19: Playing Sports Safely with Dr. Ray Deonandan
Oct 14, 2020